PHARMAKINETICS LABORATORIES INC
10-K, EX-27, 2000-09-28
TESTING LABORATORIES
Previous: PHARMAKINETICS LABORATORIES INC, 10-K, EX-23, 2000-09-28
Next: DOTRONIX INC, 10KSB40, 2000-09-28



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the Form
10-K and is qualified in its entirety by reference to such financial statement.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         346,574
<SECURITIES>                                         0
<RECEIVABLES>                                1,209,131
<ALLOWANCES>                                    47,962
<INVENTORY>                                    737,635
<CURRENT-ASSETS>                             2,468,858
<PP&E>                                       7,209,013
<DEPRECIATION>                               3,216,997
<TOTAL-ASSETS>                               6,550,186
<CURRENT-LIABILITIES>                        2,585,508
<BONDS>                                              0
                                0
                                  5,210,938
<COMMON>                                        12,481
<OTHER-SE>                                 (1,320,792)
<TOTAL-LIABILITY-AND-EQUITY>                 6,550,186
<SALES>                                      8,023,905
<TOTAL-REVENUES>                             8,230,052
<CGS>                                        8,513,540
<TOTAL-COSTS>                               11,133,806
<OTHER-EXPENSES>                                34,487
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              19,813
<INCOME-PRETAX>                            (2,958,054)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,958,054)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,958,054)
<EPS-BASIC>                                     (1.19)
<EPS-DILUTED>                                   (1.19)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission